Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 7Pancreatic Neoplasms 3Stomach Neoplasms 2Recurrence 2Neoplasms 2Nasopharyngeal Carcinoma 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Neutropenia 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Muscle Neoplasms 1Mesothelioma 1Locally Advanced Pancreatic Adenocarcinoma 1Liver Neoplasms 1Keratosis, Actinic 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Chronic Pain 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Breast Cancer Organoids 1

Interventions

folfirinox 1Leucovorin 1Gemcitabine 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Locally Advanced Pancreatic Adenocarcinoma × Fluorouracil × Clear all
NCT04423731 2024-11-20

Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)

Oslo University Hospital

Active not recruiting
251 enrolled
Gastrointestinal

Locally Advanced Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡